Table 2.
Cumulative list of unique eluted HLApMV combinations.
| Unique HLApMV | MV epitope sequence | MV epitope codea | Best HLA class I allele | Reference |
|---|---|---|---|---|
| 1 | YPALGLHEF | N.281.09 | HLA-B*07:02 | This study |
| 2 | YPALGLHEF | N.281.09 | HLA-B*35:01 | This study |
| 3 | GPRQAQVSF(L) | N.411.09 (10) | HLA-B*07:02 | This study |
| 4 | DALLRLQAM | N.493.09 | HLA-B*08:01 | This study |
| 5 | TDTPIVYNDRNL(LD) | N.512.12 (14) | NA | This study |
| 6 | EPIGSLAIEEAM | P.022.12 | HLA-B*35:01 | This study |
| 7 | YVYDHSGEAVK | P.111.11 | HLA-A*03:01 | This study |
| 8 | YVYDHSGEAVK | P.111.11 | HLA-A*11:01 | This study |
| 9 | GSAPISMGFR | P.169.10 | HLA-A*03:01 | This study |
| 10 | AEGGEIHEL | P.185.09 | HLA-B*40:01 | This study |
| 11 | FPKLGKTL | P.203.08 | HLA-B*08:01 | This study |
| 12 | KKQINRQN | P.350.08 | NA | This study |
| 13 | DTGVDTRIW | V.282.09 | NA | This study |
| 14 | AVRDLERAM | C.072.09 | HLA-C*03:04 | This study |
| 15 | AVRDLERAMTTLK | C.072.13 | HLA-A*03:01 | This study |
| 16 | KLWESPQEI | C.084.09 | HLA-A*02:01 | This study (4, 11, 21–24) |
| 17 | QEISRHQALGY | C.090.11 | HLA-B*44:02 | This study |
| 18 | GRLVPQVRVID | M.029.11 | NA | This study |
| 19 | LLKEATEL | M.090.08 | HLA-B*08:01 | This study |
| 20 | GLNEKLVFY | M.106.09 | HLA-B*15:01 | This study |
| 21 | RLSDNGYYTV | M.164.10 | HLA-A*02:01 | This study (22) |
| 22 | FRSVNAVAF | M.180.09 | HLA-C*07:02 | This study |
| 23 | GKIIDNTEQL | M.203.10 | NA | This study |
| 24 | KIIDNTEQL | M.204.09 | HLA-A*02:01 | This study |
| 25 | VIINDDQGLFKV | M.323.12 | HLA-A*02:01 | This study |
| 26 | DQGLFKVL | M.328.08 | NA | This study |
| 27 | EPIRDALNAM | F.085.10 | HLA-B*35:01 | This study |
| 28 | SMLNSQAIDNLRA | F.140.13 | HLA-A*02:01 | This study |
| 29 | RQAGQEMILAV | F.165.11 | HLA-A*02:01 | This study |
| 30 | RQAGQEMILAV | F.165.11 | HLA-B*15:01 | This study |
| 31 | RITHVDTESY | F.268.10 | HLA-B*15:01 | This study |
| 32 | GPPISLERLDVGTN | F.449.14 | NA | This study |
| 33 | RPGLKPDL | F.532.08 | HLA-B*07:02 | This study |
| 34 | LMIDRPYVL | H.030.09 | HLA-A*02:01 | This study (4, 11, 21, 23, 24) |
| 35 | AIYTAEIHK | H.064.09 | HLA-A*03:01 | This study |
| 36 | AIYTAEIHK | H.064.09 | HLA-A*11:01 | This study |
| 37 | LETRTTNQFL | H.172.10 | HLA-B*40:01 | This study |
| 38 | PTTIRGQFS | H.191.09 | NA | This study |
| 39 | GMYGGTYLVEK | H.226.11 | HLA-A*03:01 | This study |
| 40 | KPNLSSKRSEL | H.236.11 | HLA-B*07:02 | This study |
| 41 | SMYRVFEV | H.250.08 | HLA-A*02:01 | This study (22) |
| 42 | APVFHMTNY | H.267.09 | HLA-B*35:01 | This study |
| 43 | APVFHMTNYLEQPVS(N) | H.267.15 (16) | NA | This study |
| 44 | IPYQGSGKGVSF | H.308.12 | HLA-B*07:02 | This study |
| 45 | IPYQGSGKGVSF | H.308.12 | HLA-B*35:01 | This study |
| 46 | IPPMKNLAL | H.456.09 | HLA-B*08:01 | This study |
| 47 | KVSPYLFTV | H.477.09 | HLA-A*02:01 | This study |
| 48 | AEVDGDVKL | H.502.09 | HLA-B*40:01 | This study |
| 49 | ARVPHAYSL | L.0032.09 | HLA-C*07:02 | This study |
| 50 | LLKKGNSLY | L.0109.09 | HLA-B*15:01 | This study |
| 51 | DIKEKVINL | L.0144.09 | HLA-B*08:01 | This study |
| 52 | ISKESQHVY | L.0213.09 | HLA-B*15:01 | This study |
| 53 | KESQHVYYL | L.0215.09 | HLA-B*40:01 | This study |
| 54 | KLIDGFFPA | L.0263.09 | HLA-A*02:01 | This study |
| 55 | YLKDKALA | L.0463.08 | HLA-B*08:01 | This study |
| 56 | KEIKETGRLF | L.0537.10 | HLA-B*44:02 | This study |
| 57 | AENLISNGIGKY | L.0560.12 | HLA-B*44:02 | This study |
| 58 | AQRLNEIY | L.0680.08 | HLA-B*15:01 | This study |
| 59 | YESGVRIASL | L.0760.10 | HLA-B*40:01 | This study |
| 60 | IVSSHFFVY | L.0824.09 | HLA-B*15:01 | This study |
| 61 | LPAPIGGMNY | L.0933.10 | HLA-B*35:01 | This study |
| 62 | SLMPEETLHQV | L.0971.11 | HLA-A*02:01 | This study |
| 63 | MPEETLHQVM | L.0973.10 | HLA-B*35:01 | This study |
| 64 | RPIYGLEV | L.1152.08 | HLA-B*07:02 | This study |
| 65 | SAVRIATVY | L.1237.09 | HLA-B*35:01 | This study |
| 66 | (K)KVDTNFIY(QQ) | L.1325.09 (L.1326.10) | NA | This study |
| 67 | HILAKSTAL | L.1434.09 | HLA-B*08:01 | This study |
| 68 | SMIDLVTKF | L.1443.09 | HLA-B*15:01 | This study |
| 69 | HYREVNLVY | L.1936.09 | NA | This study |
| 70 | SQQGMFHAY | L.2076.09 | HLA-B*15:01 | This study |
aCode “x.(y)yyy.zz” of a measles virus peptide (pMV), in which x encodes the source protein (N, nucleocapsid; P, phosphoprotein; V, V protein; C, C protein; M, matrix protein; F, fusion protein; H, hemagglutinin; L, polymerase), (y)yyy encodes the position of the first aa in the protein, and zz represents the length of a peptide, respectively. Boxed epitopes represent identical or overlapping but differentially assigned epitope sequences.